New advances in invasive aspergillosis immunobiology leading the way towards personalized therapeutic approaches

Cytokine. 2016 Aug:84:63-73. doi: 10.1016/j.cyto.2016.05.015. Epub 2016 May 30.

Abstract

Invasive aspergillosis (IA) remains a devastating disease in immune compromised patients despite significant advances in our understanding of fungal virulence and host defense mechanisms. In this review, we summarize important research advances in the fight against IA with particular focus on early events in the interactions between Aspergillus fumigatus and the host that occur in the respiratory tract. Advances in understanding mechanisms of immune effector cell recruitment, antifungal effector mechanisms, and how the dynamic host-fungal interaction alters the local microenvironment to effect outcomes are highlighted. These advances illustrate exciting new therapeutic opportunities, but also emphasize the importance of understanding each unique fungus-host interaction for improving patient outcomes.

Keywords: Antifungal effector; Aspergillus fumigatus; Fungal virulence; Invasive aspergillosis; Phagocytes.

Publication types

  • Review

MeSH terms

  • Animals
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use
  • Aspergillosis / drug therapy
  • Aspergillosis / immunology*
  • Aspergillus fumigatus / drug effects
  • Aspergillus fumigatus / immunology*
  • Host-Pathogen Interactions / immunology
  • Humans
  • Precision Medicine

Substances

  • Antifungal Agents